Hebrew SeniorLife Appoints Harvard Medical School Assistant Professor of Medicine Dr. Ernest I. Mandel As Its Chief Medical Officer

New Chief Medical Officer Dr. Ernest I. Mandel is a clinician at both Hebrew SeniorLife and Brigham and Women’s Hospital, with an expertise in geriatric nephrology and renal palliative care.

BOSTON, MA - Harvard Medical School-affiliate Hebrew SeniorLife has appointed Ernest I. Mandel, M.D., S.M., Assistant Professor of Medicine at Harvard Medical School, as its Chief Medical Officer.

“Dr. Ernest I. Mandel is an inclusive leader with extensive administrative experience, demonstrated clinical innovation, and a record of academic accomplishment including medical education leadership,” said Mary Moscato, FACHE, President, Hebrew SeniorLife Health Care Services, Hebrew Rehabilitation Center.  

“The Department of Medicine has a long-standing history of providing outstanding quality care to the most vulnerable seniors and teaching the next generation of caregivers, and these critical efforts will only continue to grow in importance. We look forward to succeeding together under Dr. Mandel’s leadership as he applies his experience, skills, and talents as Chief Medical Officer,” she said.

About Dr. Mandel
Dr. Mandel is a clinician at both Hebrew SeniorLife and Brigham and Women’s Hospital (BWH), with an expertise in geriatric nephrology and renal palliative care. He is deeply committed to and passionate about Hebrew SeniorLife and its mission. His clinical and research interests in serious illness communication with dialysis patients led to the creation of the KidneyPal renal-palliative care service at BWH. He is committed to teaching and advancing geriatrics education, and was the Training Program Director of the BWH/MGH Joint Nephrology Fellowship, the premier training program in nephrology. Dr. Mandel received his Bachelor of Arts magna cum laude in Chemistry from Harvard University, his medical degree with honors from Yale University, and his Master of Science in epidemiology from Harvard School of Public Health. He completed his residency in internal medicine at Yale-New Haven Hospital, where he was also chief resident. He then completed a fellowship in nephrology at Brigham and Women’s Hospital and Massachusetts General Hospital. He is currently participating in the Brigham Leadership Program at Harvard Business School and is an Age-Friendly Fellow in the American Hospital Association’s Next Generation Leaders Fellowship.

Since joining Hebrew SeniorLife in 2012, Dr. Mandel has provided nephrology consultative services and served in several leadership capacities, including as Medical Director of HRC’s Medical Complex Unit where he oversaw daily clinical operations and providers, and his current positions as Medical Director of Nephrology and Dialysis and Medical Director of Quality and Safety. He also serves as co-chair of the Pharmacy and Therapeutics Committee, chair of the Infection Control and Utilization Review Committees, and a member of the Ethics and Medical Executive Committees.

Dr. Mandel will assume the role of CMO effective January 17. As CMO, Dr. Mandel will oversee the Department of Medicine, including medical staff recruitment, retention and development; physician staffing on all campuses; and physician relations activities, both internally and externally. He will continue to oversee quality improvement operations, infection control, and safety initiatives, and will lead efforts to continually enhance the patient experience, clinical delivery systems, and patient and physician satisfaction. In addition, Dr. Mandel will guide the Department of Medicine’s efforts to develop innovative clinical programs, conduct collaborative research with the Marcus Institute, and maintain HRC’s tradition of excellence in teaching Harvard Medical School medical students, residents, and fellows. Finally, he will continue to provide on-site nephrology and dialysis care as Medical Director of Nephrology and Dialysis. 

About Hebrew SeniorLife
Hebrew SeniorLife, an affiliate of Harvard Medical School, is a national senior services leader uniquely dedicated to rethinking, researching, and redefining the possibilities of aging. Hebrew SeniorLife cares for more than 3,000 seniors a day across six campuses throughout Greater Boston. Locations include: Hebrew Rehabilitation Center-Boston and Hebrew Rehabilitation Center-NewBridge in Dedham; NewBridge on the Charles, Dedham; Orchard Cove, Canton; Simon C. Fireman Community, Randolph; Center Communities of Brookline, Brookline; and Jack Satter House, Revere. Founded in 1903, Hebrew SeniorLife also conducts influential research into aging at the Hinda and Arthur Marcus Institute for Aging Research, which has a portfolio of more than $63 million, making it the largest gerontological research facility in the U.S. in a clinical setting. It also trains more than 1,000 geriatric care providers each year. For more information about Hebrew SeniorLife, visit our website or follow us on our blog, Facebook, Instagram, Twitter, and LinkedIn.